|
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
RECRUITINGSponsored by Groupe Francophone des Myelodysplasies
Actively Recruiting
SponsorGroupe Francophone des Myelodysplasies
Started2003-07-07
Est. completion2030-01-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06956755
Summary
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Male or female * Age \> 18 years * Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia * Able and willing to provide written informed consent Exclusion Criteria: * Age \<18 years * Patient is unwilling or unable to give consent
Conditions3
CancerLeukemia, Myeloid, AcuteMyelodysplastic Syndromes
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorGroupe Francophone des Myelodysplasies
Started2003-07-07
Est. completion2030-01-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06956755